Results 191 to 200 of about 3,012,873 (295)

Signal-quality-aware multisensor fusion for atrial fibrillation detection. [PDF]

Healthc Technol Lett
Malone S, Cardiff B, John D, John A.
europepmc   +1 more source

Automated Signal Quality Assessment of Single-Lead ECG Recordings for Early Detection of Silent Atrial Fibrillation. [PDF]

Sensors (Basel), 2023
Lueken M, Gramlich M, Leonhardt S, Marx N, Zink MD.   +4 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Signal Quality Assessment and Reconstruction of PPG-Derived Signals for Heart Rate and Variability Estimation in In-Vehicle Applications: A Comparative Review and Empirical Validation. [PDF]

Sensors (Basel)
Gao R, Miller CS, Lin BTW, Schwarz CW, Jones MLH.   +4 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Comparative analysis of signal quality and usability for a novel wireless, wearable EEG sensor. [PDF]

Clin Neurophysiol Pract
Muvvala VK, Kazen AB, Newton TJ, Tosi Z, Elwood M, Lehmkuhle MJ, Loddenkemper T, Spitz MC, Strom L, Friedman D, Frankel MA.   +10 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

A Paralleled Multi-Task Learning-Based Framework for Single-Lead ECG Fine-Grained Noise Localization, Denoising and Signal Quality Assessment. [PDF]

Sensors (Basel)
Hu Y, Liu Q, Zhou Z, Xu W, Tang H.
europepmc   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Cortical bone mechanics technology signal quality maintains robustness across a range of biometric profiles. [PDF]

JBMR Plus
Dick A, Stoeckel M, Ruzzenne M, von Sadovszky T, Simon JE, Clark LA, Warden SJ, Manini TM, Lyssikatos C, Hart T, Clark BC.   +10 more
europepmc   +1 more source